Teva to eliminate 14,000 jobs in major restructuring overhaul

Teva Pharmaceutical Industries Ltd. is eliminating 14,000 positions globally — more that 25 percent of its total work force — over the next two years as part of a major restructuring plan designed to save the company $3 billion by the end of 2019. The restructuring plan will also include the closure or divestment of a “significant number” of R&D facilities, headquarters and other Teva office locations across around the world. Company officials were not immediately available to comment on…
Source: bizjournals.com Health Care:Pharmaceuticals headlines - Category: Pharmaceuticals Authors: Source Type: news